Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-04-03 Sale |
2024-04-05 4:55 pm |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO GENERAL COUNSEL SECRETARY |
27,578 | $0 | $0 | 0 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2025-06-09 Option Award |
2025-06-11 5:47 pm |
N/A 2035-06-08 |
Lyell Immunopharma Inc. | LYEL | Meltz Mark A General Counsel |
100,000 | $0 | 100,000 (Direct) |
View |
| 2024-03-01 Tax Withholding |
2024-03-05 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO GENERAL COUNSEL SECRETARY |
558 | $2.59 | 27,578 (Direct) |
View |
| 2023-12-01 Tax Withholding |
2023-12-05 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
541 | $2.25 | 28,136 (Direct) |
View |
| 2023-09-01 Tax Withholding |
2023-09-06 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
541 | $2.35 | 28,677 (Direct) |
View |
| 2023-06-01 Tax Withholding |
2023-06-05 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
541 | $4.3 | 29,218 (Direct) |
View |
| 2023-03-01 Tax Withholding |
2023-03-03 5:57 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
638 | $5.21 | 27,286 (Direct) |
View |
| 2023-02-10 Option Award |
2023-02-14 5:00 pm |
N/A 2033-02-10 |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
215,000 | $0 | 215,000 (Direct) |
View |
| 2022-12-01 Tax Withholding |
2022-12-02 8:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
541 | $7.75 | 27,924 (Direct) |
View |
| 2022-09-01 Option Award |
2022-09-02 5:00 pm |
N/A N/A |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Secretary |
25,000 | $0 | 28,465 (Direct) |
View |
| 2022-02-11 Option Award |
2022-02-15 4:01 pm |
N/A 2032-02-11 |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer |
135,000 | $0 | 135,000 (Direct) |
View |
| 2021-02-12 Option Award |
2021-02-16 6:00 pm |
N/A 2031-02-12 |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer |
100,000 | $0 | 100,000 (Direct) |
View |
Ownership |
2020-12-02 9:12 pm |
2020-04-02 2030-04-02 |
Kinnate Biopharma Inc. | KNTE | Meltz Mark A COO General Counsel Treasurer |
0 | $0 | 506,011 (Direct) |
View |